Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 45 and 69
years old
The phase for this study is not defined.
Show me locations

The purpose

Comparison of survival in patients with or without a matched donor at 36 months

Provided treatments

  • Other: transplantation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02757989. The sponsor of the trial is Groupe Francophone des Myelodysplasies and it is looking for 105 volunteers for the current phase.
Official trial title:
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Low or Intermediate-1 Myelodysplastic Syndrome: A Prospective Multicenter Phase II Study Based on Donor Availability on Behalf of the GFM & SFGM-TC